Dr Reddy's Laboratories reports standalone net profit of Rs 223.00 crore in the March 2017 quarter

Capital Market May 12, 2017 Last Updated at 16:27 IST

Sales decline 2.72% to Rs 2303.40 crore

Net profit of Dr Reddy's Laboratories reported to Rs 223.00 crore in the quarter ended March 2017 as against net loss of Rs 38.60 crore during the previous quarter ended March 2016. Sales declined 2.72% to Rs 2303.40 crore in the quarter ended March 2017 as against Rs 2367.90 crore during the previous quarter ended March 2016.

For the full year,net profit rose 0.71% to Rs 1384.10 crore in the year ended March 2017 as against Rs 1374.30 crore during the previous year ended March 2016. Sales declined 5.93% to Rs 9628.10 crore in the year ended March 2017 as against Rs 10234.80 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales2303.402367.90 -3 9628.1010234.80 -6 OPM %13.430.16 -18.1320.18 - PBDT353.00116.30 204 2279.602326.10 -2 PBT163.40-64.80 LP 1544.501676.60 -8 NP223.00-38.60 LP 1384.101374.30 1

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)